Case Reports
doi: 10.1136/bjo.2007.114843.
Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female
- PMID: 17947276
- PMCID: PMC2095440
- DOI: 10.1136/bjo.2007.114843
Item in Clipboard
Case Reports
Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female
Br J Ophthalmol.
2007 Nov.
No abstract available
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.Arch Ophthalmol. 2004 Aug;122(8):1131-6. doi: 10.1001/archopht.122.8.1131. Arch Ophthalmol. 2004. PMID: 15302652
-
Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone.Acta Ophthalmol Scand. 2006 Jun;84(3):314-8. doi: 10.1111/j.1600-0420.2005.00605.x. Acta Ophthalmol Scand. 2006. PMID: 16704690
-
Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.Br J Ophthalmol. 2004 Jan;88(1):154-5. doi: 10.1136/bjo.88.1.154. Br J Ophthalmol. 2004. PMID: 14693796 Free PMC article. No abstract available.
-
Intravitreal steroids in the management of macular oedema.Acta Ophthalmol Scand. 2006 Dec;84(6):722-33. doi: 10.1111/j.1600-0420.2006.00698.x. Acta Ophthalmol Scand. 2006. PMID: 17083528 Review.
-
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. doi: 10.1111/j.1600-0420.2005.00592.x. Acta Ophthalmol Scand. 2005. PMID: 16396641 Review.
Cited by
-
Optic neuritis secondary to antiandrogen therapy.Ir J Med Sci. 2017 Aug;186(3):565-570. doi: 10.1007/s11845-016-1544-1. Epub 2016 Dec 30. Ir J Med Sci. 2017. PMID: 28039596 Review.
-
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007324. doi: 10.1002/14651858.CD007324.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2015 Sep 09;(9):CD007324. doi: 10.1002/14651858.CD007324.pub3. PMID: 19160332 Free PMC article. Updated.
-
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.Cochrane Database Syst Rev. 2015 Sep 9;2015(9):CD007324. doi: 10.1002/14651858.CD007324.pub3. Cochrane Database Syst Rev. 2015. PMID: 26352007 Free PMC article.
References
-
- The Eye Disease Case‐Control Study Group Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996114545–554. - PubMed
-
- Dodson P M, Kritzinger E E. Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion. Trans Ophthalmol Soc UK 1985104114–119. - PubMed
-
- Fong A C O, Shatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol 199337393–417. - PubMed
-
- Diane‐35 [product monograph]. In: Compendium of pharmaceuticals and specialties. Ottawa: Canadian Pharmacists Association, 2002493–495.
-
- Stowe G C I I I, Zakov Z N, Albert D M. Central retinal vascular occlusion associated with oral contraceptives. Am J Ophthalmol 197886798–801. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
